Please provide your email address to receive an email when new articles are posted on . In a small study, cardiopulmonary exercise testing identified significant abnormalities, including dysfunctional ...

Correspondence to Dr Meagan M Wasfy, Cardiovascular Performance Program, Massachusetts General Hospital, Boston, MA 02114, USA; mwasfy{at}partners.org Objectives Persistent or late-onset ...

In a recent study posted to the medRxiv* pre-print server, researchers demonstrated reduced exercise capacity due to persistent cardiopulmonary symptoms among coronavirus disease 2019 (COVID-19) ...

The assessment of patients with suspected or confirmed pulmonary arterial hypertension (PAH) and secondary pulmonary hypertension (PH) continues to evolve and, in recent years, evidence demonstrating ...

Many patients with symptoms of long COVID have reduced exercise capacity, which if better understood might be helpful in managing their treatment, according to a systematic review and meta-analysis of ...

Patients who have unexplained dyspnea months after recovering from COVID-19 often have objective signs of breathing problems on cardiopulmonary exercise testing (CPET) and meet criteria for myalgic ...

"ATTR amyloidosis was characterized by distinct patterns of functional impairment across all disease phenotypes, attributable to multiple physiological mechanisms. Multiple CPET parameters were ...

Cardiopulmonary exercise testing (CPET), also known as ergospirometry, can be used for early detection of respiratory disorders in overweight and obese individuals. This is the main finding of a study ...

Did you know that traditional Cardiopulmonary Exercise Testing (CPET) can cost hundreds of dollars per session and often requires bulky equipment and hospital visits? For many runners, this makes ...

Correspondence to Dr Robert I Liem, Division of Hematology, Oncology & Stem Cell Transplant, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; rliem{at}luriechildrens.org ...

Pharmacodynamic separation (PDS) of gemcitabine (Gem) and the epidermal growth factor receptor (EGFR) inhibitor erlotinib (E) in patients (Pts) with advanced pancreatic cancer: Phase II results. This ...

Echocardiography Echocardiography in association with CPX may provide a more thorough evaluation of CV and pulmonary physiology in patients with suspected PAH, although research is needed in this area ...